2024
Supervised Disulfiram Should Be Considered First-line Treatment for Alcohol Use Disorder
Holt S. Supervised Disulfiram Should Be Considered First-line Treatment for Alcohol Use Disorder. Journal Of Addiction Medicine 2024, 18: 614-616. PMID: 39150091, DOI: 10.1097/adm.0000000000001345.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAlcohol use disorderSupervised disulfiramUse disorderAlcohol use disorder treatmentPrevalence of alcohol use disordersFDA-approved medicationsRandomized Controlled TrialsFirst-line interventionBehavioral interventionsDouble-Blind Randomized Controlled TrialApproved medicationsDisulfiramOpen-label randomized controlled trialSecond-line optionFirst-line treatmentNational treatment guidelinesDisordersTherapeutic resourcesEfficacy dataMedicationTreatment guidelinesAddictionControlled TrialsInterventionPatient preferences
2023
The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder
Castagna P, Farahdel E, Potenza M, Crowley M. The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder. Expert Opinion On Pharmacotherapy 2023, 24: 835-847. PMID: 37074259, PMCID: PMC10197951, DOI: 10.1080/14656566.2023.2199921.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsSelective serotonin reuptake inhibitorsSelective norepinephrine reuptake inhibitorGeneralized anxiety disorderAnxiety disordersReuptake inhibitorsPediatric generalized anxiety disorderBetter long-term outcomesSecond-line treatmentNorepinephrine reuptake inhibitorsSerotonin reuptake inhibitorsFirst-line interventionLong-term outcomesCombination of psychotherapyPrevalent psychiatric disordersEvidence-based statePediatric anxiety disordersArt pharmacotherapyModerate effect sizeFunctional outcomeEarly recognitionMood disordersElevated riskPsychiatric disordersBetter outcomesElectronic databases
2021
Core CBT Components
Purvis L, Zaboski B, Joyce-Beaulieu D. Core CBT Components. 2021, 101-116. DOI: 10.1093/med-psych/9780197581384.003.0006.Peer-Reviewed Original ResearchCognitive behavioral therapyCognitive restructuringBehavioral activationMaladaptive thoughtsThought recordsCBT componentsBehavioral therapyMood disturbanceFirst-line interventionIntervention processThoughtChapter 6Core componentAnhedoniaAdolescentsDemotivationDepressionChildrenPractitionersRestructuringInterventionClientsValidity
2020
Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders
Ray LA, Meredith LR, Kiluk BD, Walthers J, Carroll KM, Magill M. Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders. JAMA Network Open 2020, 3: e208279. PMID: 32558914, PMCID: PMC7305524, DOI: 10.1001/jamanetworkopen.2020.8279.Peer-Reviewed Original ResearchConceptsSubstance use disordersAdult alcohol use disordersCognitive behavioral therapyUsual careRandomized clinical trialsUse disordersBehavioral therapySpecific therapyClinical trialsAddition of CBTSuperiority of CBTTreatment of SUDsUsual clinical managementForms of pharmacotherapyFirst-line interventionEvidence-based therapiesClinical trial samplesEvidence-based modalitiesAlcohol use disorderEnglish-language articlesPublic health concernFull-text articlesEffect sizeCochrane RegisterRandom effects estimates
2018
Obsessive-compulsive and related disorders.
Tolin D, Springer K. Obsessive-compulsive and related disorders. 2018, 455-479. DOI: 10.1037/0000064-019.Peer-Reviewed Original ResearchObsessive-compulsive disorderCognitive behavioral therapyBody dysmorphic disorderFifth editionPsychological modelsDysmorphic disorderReview researchDSM-5First-line interventionRelated disordersExcoriation disorderStatistical ManualOCRDsSomatic treatmentsDisordersTreatment outcomesSubstantial evidenceCompulsionObsessionTrichotillomaniaSymptomsAssociated burdenEditionInterventionClear need
2017
Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment
Hirschtritt ME, Bloch MH, Mathews CA. Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment. JAMA 2017, 317: 1358-1367. PMID: 28384832, DOI: 10.1001/jama.2017.2200.Peer-Reviewed Original ResearchConceptsSelective serotonin reuptake inhibitorsSerotonin reuptake inhibitorsObsessive-compulsive disorderCognitive behavioral therapyTreatment of OCDReuptake inhibitorsBehavioral therapySystematic reviewFirst-line pharmacologic interventionPreferred initial treatment strategyTreatment-resistant obsessive-compulsive disorderInitial treatment strategyPrimary care settingTreatment-resistant casesDiagnosis of OCDFirst-line interventionEfficacy of neurolepticsDeep brain stimulationComputer-based cognitive behavioral therapyCase seriesPharmacologic interventionsAdjunctive useTreatment optionsTreatment advancesNeuromodulatory approachesExercise, metabolic syndrome, and cardiovascular fitness in breast cancer survivors.
Knobf M, Sinusas A, Holland M, Jeon S. Exercise, metabolic syndrome, and cardiovascular fitness in breast cancer survivors. Journal Of Clinical Oncology 2017, 35: 165-165. DOI: 10.1200/jco.2017.35.5_suppl.165.Peer-Reviewed Original ResearchBreast cancer survivorsPhysical activity groupHeart rate recoveryMetabolic syndromeCancer survivorsLifestyle behaviorsCardiovascular diseaseRate recoveryCardiovascular fitnessAge-matched postmenopausal womenBreast cancer-specific mortalityActivity groupHigh baseline incidenceCancer-specific mortalityFirst-line interventionCause mortalityEndocrine therapyPostmenopausal womenExercise interventionMetS componentsMetS criteriaDiastolic BPSystolic BPMonths interventionMetabolic outcomes
2016
Long-term survival in AIDS-related primary central nervous system lymphoma
Gupta NK, Nolan A, Omuro A, Reid EG, Wang CC, Mannis G, Jaglal M, Chavez JC, Rubinstein PG, Griffin A, Abrams DI, Hwang J, Kaplan LD, Luce JA, Volberding P, Treseler PA, Rubenstein JL. Long-term survival in AIDS-related primary central nervous system lymphoma. Neuro-Oncology 2016, 19: 99-108. PMID: 27576871, PMCID: PMC5193026, DOI: 10.1093/neuonc/now155.Peer-Reviewed Original ResearchConceptsCombination antiretroviral therapyWhole brain radiotherapyPrimary central nervous system lymphomaCentral nervous system lymphomaAR-PCNSLNervous system lymphomaHD-MTXLong-term survivalMulticenter analysisSystem lymphomaAdvent of cARTLong-term disease-free survivalLonger progression-free survivalSan Francisco General HospitalHigh-dose methotrexateDisease-free survivalProgression-free survivalOptimal therapeutic approachTherapy-related factorsFirst-line interventionPost-cART eraLong-term toxicityAntiretroviral therapyBrain radiotherapyFavorable survival
2015
Tic disorders
Leckman J, Bloch M. Tic disorders. 2015, 757-773. DOI: 10.1002/9781118381953.ch56.Peer-Reviewed Original ResearchPsychological processesCognitive-behavioral treatmentTourette syndromeEmotional processingCourse of developmentNeural mechanismsInhibitory controlBehavioral treatmentFirst-line interventionPathogenesis of TSEnvironmental influencesPathways of careTic disordersDelivery of careMotor regulationSensorimotor gatingTherapeutic algorithmClinical presentationDisordersRelated disordersTreatment trialsClinical expressionOrphan disorderExperienced cliniciansPathogenesis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply